Equifax Inc (EFX) Stock Forecast Oct. 15, 2026
Analysis updated on Oct. 15, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Equifax Inc (EFX) stock forecast summary
On Oct. 15, 2026, EFX is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5111 stocks scored that day.
Equifax Inc is a large-cap company with a market capitalization of $17.67B.
For EFX, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 12.0%, measured on 358 forecast dates between 2022-07-28 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 400 forecast dates between 2022-07-28 and 2026-09-15. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.5% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-15 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, EFX included.
Follow EFX freeEFX price chart and AI forecast
How EFX ranks among 5111 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Equifax Inc (EFX) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Consumer Credit Reporting, Collection Agencies peers listed below that report each metric.
Valuation & Market
| Metric | EFX | Rank |
|---|---|---|
| Market Cap | $17.67B | – |
| P/E Ratio | 26.43x | – |
| P/B Ratio | 4.03x | – |
| Dividend Yield | 1.45% | – |
| EPS | $5.69 | – |
| Book Value/Share | $37.28 | – |
| Revenue/Share | $54.85 | – |
| FCF/Share | $9.41 | – |
Profitability & Margins
| Metric | EFX | Rank |
|---|---|---|
| ROE | 15.8% | – |
| ROA | 5.8% | – |
| ROIC | 12.3% | – |
| Gross Margin | 55.5% | – |
| Operating Margin | 17.9% | – |
| Net Margin | 10.7% | – |
| EBT Margin | 14.6% | – |
| Tax Rate | 26.0% | – |
Financial Health
| Metric | EFX | Rank |
|---|---|---|
| Current Ratio | 0.60x | – |
| D/E Ratio | 1.70x | – |
| Financial Leverage | 2.74x | – |
| Interest Coverage | 1.4x | – |
| Working Capital | -$1.04B | – |
Cash Flow
| Metric | EFX | Rank |
|---|---|---|
| Operating Cash Flow | $1.61B | – |
| Free Cash Flow | $1.10B | – |
| Capital Spending | -$507M | – |
| OCF Growth YoY | 16.1% | – |
| FCF Growth YoY | 20.5% | – |
| FCF/Sales | 17.1% | – |
| CapEx/Sales | 7.9% | – |
Operational Efficiency
| Metric | EFX | Rank |
|---|---|---|
| Asset Turnover | 0.54x | – |
| Receivables Turnover | 5.8x | – |
| Fixed Assets Turnover | 3.3x | – |
| Days Sales Outstanding | 63 days | – |
| Payables Period | 16 days | – |
Income Statement
| Metric | EFX | Rank |
|---|---|---|
| Total Revenue | $6.44B | – |
| Operating Income | $1.15B | – |
| Net Income | $691M | – |
| SG&A Expense | $1.69B | – |
| Cost of Goods Sold | $2.87B | – |
Dividend & Shareholder Information
| Metric | EFX | Rank |
|---|---|---|
| Dividends Per Share | $2.18 | – |
| Payout Ratio | 38.3% | – |
| Shares Outstanding | 117M | – |
| Net Income Growth | 8.1% | – |
| EPS Growth | 11.1% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1.58B | 13.2% of assets |
| Cash & Short-term Investments | $170M | 1.4% of assets |
| Accounts Receivable | $1.10B | 9.2% of assets |
| Total Liabilities | $7.46B | 62.3% of assets |
| Short-term Debt | $2.50B | 20.9% of assets |
EFX quarterly financials and insider trading
Equifax Inc (EFX) industry peers
Companies classified under the same SEC industry code as Equifax Inc (Services-Consumer Credit Reporting, Collection Agencies): 4 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere EFX sits on the market map
Equifax Inc (EFX) stock news
Loading...
Equifax Inc (EFX) stock forecast FAQ
What is the Equifax Inc (EFX) stock forecast?
On Oct. 15, 2026, EFX is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5111 stocks scored that day.
How accurate are Equifax Inc stock predictions?
For EFX, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 12.0%, measured on 358 forecast dates between 2022-07-28 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 400 forecast dates between 2022-07-28 and 2026-09-15. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Equifax Inc forecasts updated?
Equifax Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 15, 2026.
Which companies are Equifax Inc's industry peers?
4 issuers in our coverage, EFX included, share the SEC industry code Services-Consumer Credit Reporting, Collection Agencies. The largest are: S&P Global Inc. (SPGI), Moodys Corp /De/ (MCO), Creditriskmonitor Com Inc (CRMZ).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.